Blue­bird bio may fi­nal­ly get a gene ther­a­py ap­proved in the US

Blue­bird bio may, at long last, get a gene ther­a­py ap­proved in the US.

The Cam­bridge, MA biotech an­nounced Mon­day that the FDA had ac­cept­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.